Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

WHO compiles a compendium of 24 new technologies for COVID-19 and other priority diseases

The COVID-19 pandemic has highlighted the need for innovative health technologies that can help countries improve health outcomes by providing shortcuts to solutions despite lack of infrastructure and resources.

4 Sep 2021

NIH awards $18.15 million to seven projects focused on interoception

The National Institutes of Health is awarding seven projects a total of $18.15 million over five years to a new effort focused on interoception—the ways in which organisms sense and regulate signals within their bodies.

4 Sep 2021

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

A new study analyzed the post-boost binding and functional capacity of the humoral response induced by the Pfizer-BioNTech and Moderna vaccines.

3 Sep 2021

New online tool to help medical staff quickly support COVID-19 patients

Researchers at Case Western Reserve University have developed an online tool to help medical staff quickly determine which COVID-19 patients will need help breathing with a ventilator.

3 Sep 2021

Your covid game plan: Are stadiums safe?

The college football season is kicking into high gear, the National Football League season starts Sept. 9, and the baseball pennant races are heating up. For the first time since 2019, nearly all stadiums will be fully open to fans.

3 Sep 2021

People who received two vaccine doses have lower odds of experiencing long COVID

People who tested positive for SARS-CoV-2 after one or two vaccine doses had significantly lower odds of severe disease or hospitalization than unvaccinated people, according to a large-scale study investigating COVID-19 breakthrough infections published in The Lancet Infectious Diseases journal.

2 Sep 2021

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.

2 Sep 2021

Double vaccination reduces the risk of Long COVID by almost half

Adults who have received a double vaccination are 49% less likely to have Long COVID should they contract a COVID-19 infection.

2 Sep 2021

New computational approach may predict how individuals are likely to respond to vaccines

In an advance that sheds light on why certain vaccines may influence people differently, a new computational approach developed at the University of Michigan may predict how individual patients are likely to respond.

2 Sep 2021

New walk-through coronavirus testing facility opened in Bangor

A new walk-through coronavirus testing facility has opened for those with symptoms to book appointments at Beach Street Car Park West (LL57 1AT) in Bangor, as part of the UK Government's UK-wide drive to continue to improve the accessibility of coronavirus testing for local communities.

2 Sep 2021

Should pregnant women be vaccinated against COVID-19?

A recent study examines whether COVID-19 risks in pregnant women justify the administration of COVID-19 vaccines to pregnant individuals.

2 Sep 2021

Increased evolutionary rates seen in SARS-CoV-2 variants of concern

An Australian study conducted at the University of Melbourne describes that the emergence of more deadly variants of concern (VOCs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with an induction in episodic evolutionary rate. The study is currently available on the medRxiv* preprint server.

2 Sep 2021

Study identifies how immune sensors launch a multi-faceted innate immune response to infections

St. Jude Children's Research Hospital immunologists have identified how immune sensors in infected cells organize and launch a multi-faceted innate immune response to infections with live viruses and bacteria. The discovery appears today in Nature.

2 Sep 2021

Immune cells present in tumors from head and neck cancer patients, study reports

A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the major targets of immune checkpoint inhibitors are present in tumors from head and neck cancer patients.

2 Sep 2021

Regional differences in prevalence of SARS-CoV-2 antibodies in children

A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.

2 Sep 2021

Immune cell betrayal makes aging mice less tolerant of cold temperatures

Human evolution has provided us a level of protection from the existential threat of cold temperature with the capacity to produce heat from fat stored in the body.

1 Sep 2021

Sequential treatment using similar antibiotics can kill bacteria and prevent drug resistance

equential treatment using antibiotics that are similar but swapped around frequently is an effective way to kill bacteria and prevent drug resistance, a study in eLife reports.

1 Sep 2021

A global genetic surveillance gap for SARS-CoV-2

Now a new study posted to the medRxiv* preprint server provides a perspective on the global disparities surrounding SARS-CoV-2 genomic surveillance, their causes and consequences, and possible solutions to maximize the impact of pathogen genome sequencing for efforts on public health.

1 Sep 2021

Attenuated virulence and protective immunity in SARS-CoV-2 with a mutation in the S1/S2 cleavage site

A new study published in mBio investigates the impact of the furin cleavage site on viral growth and pathogenesis.

31 Aug 2021

Investigational vaccine does not provide sufficient protection against HIV infection

An investigational HIV vaccine tested in the "Imbokodo" clinical trial conducted in sub-Saharan Africa posed no safety concerns but did not provide sufficient protection against HIV infection, according to a primary analysis of the study data. The Phase 2b proof-of-concept study, which began in November 2017, enrolled 2,637 women ages 18 to 35 years from five countries.

31 Aug 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

WHO compiles a compendium of 24 new technologies for COVID-19 and other priority diseases

NIH awards $18.15 million to seven projects focused on interoception

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

New online tool to help medical staff quickly support COVID-19 patients

Your covid game plan: Are stadiums safe?

People who received two vaccine doses have lower odds of experiencing long COVID

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

Double vaccination reduces the risk of Long COVID by almost half

New computational approach may predict how individuals are likely to respond to vaccines

New walk-through coronavirus testing facility opened in Bangor

Should pregnant women be vaccinated against COVID-19?

Increased evolutionary rates seen in SARS-CoV-2 variants of concern

Study identifies how immune sensors launch a multi-faceted innate immune response to infections

Immune cells present in tumors from head and neck cancer patients, study reports

Regional differences in prevalence of SARS-CoV-2 antibodies in children

Immune cell betrayal makes aging mice less tolerant of cold temperatures

Sequential treatment using similar antibiotics can kill bacteria and prevent drug resistance

A global genetic surveillance gap for SARS-CoV-2

Attenuated virulence and protective immunity in SARS-CoV-2 with a mutation in the S1/S2 cleavage site

Investigational vaccine does not provide sufficient protection against HIV infection

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in